Hirakata, Japan

Hajime Fukuyama

This inventor holds 2 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1996-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hajime Fukuyama. Retrieved from https://idiyas.com/inventor/hajime-fukuyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hajime Fukuyama: Innovator in Pharmaceutical Compounds

Introduction

Hajime Fukuyama is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on heterocyclic amide compounds. With a total of 2 patents to his name, Fukuyama continues to push the boundaries of medical science.

Latest Patents

Fukuyama's latest patents include "Heterocyclic amide compounds and pharmaceutical use of the same" and "Liquid preparation of antithrombin-III and stabilizing method therefor." These inventions showcase his expertise in developing new pharmaceutical formulations that can potentially improve patient outcomes.

Career Highlights

Fukuyama is currently employed at The Green Cross Corporation, where he applies his knowledge and skills to advance the company's research and development efforts. His work is instrumental in creating innovative solutions for various medical challenges.

Collaborations

Throughout his career, Fukuyama has collaborated with talented individuals such as Fumihiko Akahoshi and Takuya Yoshimura. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Hajime Fukuyama is a distinguished inventor whose contributions to pharmaceutical science are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical research and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…